The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions
- 1 March 2003
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 37 (3), 512-517
- https://doi.org/10.1067/mva.2003.41
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Alteplase as an Alternative to UrokinaseJournal of Vascular and Interventional Radiology, 2000
- Complications Associated with the Use of Urokinase and Recombinant Tissue Plasminogen Activator for Catheter-directed Peripheral Arterial and Venous ThrombolysisJournal of Vascular and Interventional Radiology, 2000
- Bioactivity of cryopreserved alteplase solutionsAmerican Journal of Health-System Pharmacy, 1999
- Recommended standards for reports dealing with lower extremity ischemia: Revised versionJournal of Vascular Surgery, 1997
- Local Thrombolytic Therapy as Part of a Multidisciplinary Approach to Acute Axillosubclavian Vein Thrombosis (Paget-Schroetter Syndrome)Journal of Vascular and Interventional Radiology, 1997
- Surgery versus Thrombolytic Therapy in the Management of Peripheral Arterial OcclusionsJournal of Vascular and Interventional Radiology, 1995
- A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemiaJournal of Vascular Surgery, 1994
- Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis.Radiology, 1994
- Low-Dose Urokinase Regimen for the Treatment of Lower Extremity Arterial and Graft Occlusions: Experience in 132 CasesJournal of Vascular and Interventional Radiology, 1992
- The role of thrombolytic therapy in surgical practiceBritish Journal of Surgery, 1989